Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A Virus-Binding Hot Spot on Human Angiotensin-Converting Enzyme 2 Is Critical for Binding of Two Different Coronaviruses▿

Identifieur interne : 000C65 ( Pmc/Corpus ); précédent : 000C64; suivant : 000C66

A Virus-Binding Hot Spot on Human Angiotensin-Converting Enzyme 2 Is Critical for Binding of Two Different Coronaviruses▿

Auteurs : Kailang Wu ; Lang Chen ; Guiqing Peng ; Wenbo Zhou ; Christopher A. Pennell ; Louis M. Mansky ; Robert J. Geraghty ; Fang Li

Source :

RBID : PMC:3094985

Abstract

How viruses evolve to select their receptor proteins for host cell entry is puzzling. We recently determined the crystal structures of NL63 coronavirus (NL63-CoV) and SARS coronavirus (SARS-CoV) receptor-binding domains (RBDs), each complexed with their common receptor, human angiotensin-converting enzyme 2 (hACE2), and proposed the existence of a virus-binding hot spot on hACE2. Here we investigated the function of this hypothetical hot spot using structure-guided biochemical and functional assays. The hot spot consists of a salt bridge surrounded by hydrophobic tunnel walls. Mutations that disturb the hot spot structure have significant effects on virus/receptor interactions, revealing critical energy contributions from the hot spot structure. The tunnel structure at the NL63-CoV/hACE2 interface is more compact than that at the SARS-CoV/hACE2 interface, and hence RBD/hACE2 binding affinities are decreased either by NL63-CoV mutations decreasing the tunnel space or by SARS-CoV mutations increasing the tunnel space. Furthermore, NL63-CoV RBD inhibits hACE2-dependent transduction by SARS-CoV spike protein, a successful application of the hot spot theory that has the potential to become a new antiviral strategy against SARS-CoV infections. These results suggest that the structural features of the hot spot on hACE2 were among the driving forces for the convergent evolution of NL63-CoV and SARS-CoV.


Url:
DOI: 10.1128/JVI.02274-10
PubMed: 21411533
PubMed Central: 3094985

Links to Exploration step

PMC:3094985

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A Virus-Binding Hot Spot on Human Angiotensin-Converting Enzyme 2 Is Critical for Binding of Two Different Coronaviruses
<xref ref-type="fn" rid="FN1">
<sup></sup>
</xref>
</title>
<author>
<name sortKey="Wu, Kailang" sort="Wu, Kailang" uniqKey="Wu K" first="Kailang" last="Wu">Kailang Wu</name>
<affiliation>
<nlm:aff id="aff1">Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Chen, Lang" sort="Chen, Lang" uniqKey="Chen L" first="Lang" last="Chen">Lang Chen</name>
<affiliation>
<nlm:aff id="aff1">Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Peng, Guiqing" sort="Peng, Guiqing" uniqKey="Peng G" first="Guiqing" last="Peng">Guiqing Peng</name>
<affiliation>
<nlm:aff id="aff1">Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Wenbo" sort="Zhou, Wenbo" uniqKey="Zhou W" first="Wenbo" last="Zhou">Wenbo Zhou</name>
<affiliation>
<nlm:aff id="aff2">Center for Drug Design, University of Minnesota, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Pennell, Christopher A" sort="Pennell, Christopher A" uniqKey="Pennell C" first="Christopher A." last="Pennell">Christopher A. Pennell</name>
<affiliation>
<nlm:aff id="aff3">Cancer Center, Center for Immunology, University of Minnesota, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mansky, Louis M" sort="Mansky, Louis M" uniqKey="Mansky L" first="Louis M." last="Mansky">Louis M. Mansky</name>
<affiliation>
<nlm:aff id="aff4">Institute for Molecular Virology and Departments of Diagnostic and Biological Sciences and Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Geraghty, Robert J" sort="Geraghty, Robert J" uniqKey="Geraghty R" first="Robert J." last="Geraghty">Robert J. Geraghty</name>
<affiliation>
<nlm:aff id="aff2">Center for Drug Design, University of Minnesota, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Li, Fang" sort="Li, Fang" uniqKey="Li F" first="Fang" last="Li">Fang Li</name>
<affiliation>
<nlm:aff id="aff1">Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">21411533</idno>
<idno type="pmc">3094985</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094985</idno>
<idno type="RBID">PMC:3094985</idno>
<idno type="doi">10.1128/JVI.02274-10</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000C65</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000C65</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">A Virus-Binding Hot Spot on Human Angiotensin-Converting Enzyme 2 Is Critical for Binding of Two Different Coronaviruses
<xref ref-type="fn" rid="FN1">
<sup></sup>
</xref>
</title>
<author>
<name sortKey="Wu, Kailang" sort="Wu, Kailang" uniqKey="Wu K" first="Kailang" last="Wu">Kailang Wu</name>
<affiliation>
<nlm:aff id="aff1">Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Chen, Lang" sort="Chen, Lang" uniqKey="Chen L" first="Lang" last="Chen">Lang Chen</name>
<affiliation>
<nlm:aff id="aff1">Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Peng, Guiqing" sort="Peng, Guiqing" uniqKey="Peng G" first="Guiqing" last="Peng">Guiqing Peng</name>
<affiliation>
<nlm:aff id="aff1">Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Wenbo" sort="Zhou, Wenbo" uniqKey="Zhou W" first="Wenbo" last="Zhou">Wenbo Zhou</name>
<affiliation>
<nlm:aff id="aff2">Center for Drug Design, University of Minnesota, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Pennell, Christopher A" sort="Pennell, Christopher A" uniqKey="Pennell C" first="Christopher A." last="Pennell">Christopher A. Pennell</name>
<affiliation>
<nlm:aff id="aff3">Cancer Center, Center for Immunology, University of Minnesota, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mansky, Louis M" sort="Mansky, Louis M" uniqKey="Mansky L" first="Louis M." last="Mansky">Louis M. Mansky</name>
<affiliation>
<nlm:aff id="aff4">Institute for Molecular Virology and Departments of Diagnostic and Biological Sciences and Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Geraghty, Robert J" sort="Geraghty, Robert J" uniqKey="Geraghty R" first="Robert J." last="Geraghty">Robert J. Geraghty</name>
<affiliation>
<nlm:aff id="aff2">Center for Drug Design, University of Minnesota, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Li, Fang" sort="Li, Fang" uniqKey="Li F" first="Fang" last="Li">Fang Li</name>
<affiliation>
<nlm:aff id="aff1">Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of Virology</title>
<idno type="ISSN">0022-538X</idno>
<idno type="eISSN">1098-5514</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>How viruses evolve to select their receptor proteins for host cell entry is puzzling. We recently determined the crystal structures of NL63 coronavirus (NL63-CoV) and SARS coronavirus (SARS-CoV) receptor-binding domains (RBDs), each complexed with their common receptor, human angiotensin-converting enzyme 2 (hACE2), and proposed the existence of a virus-binding hot spot on hACE2. Here we investigated the function of this hypothetical hot spot using structure-guided biochemical and functional assays. The hot spot consists of a salt bridge surrounded by hydrophobic tunnel walls. Mutations that disturb the hot spot structure have significant effects on virus/receptor interactions, revealing critical energy contributions from the hot spot structure. The tunnel structure at the NL63-CoV/hACE2 interface is more compact than that at the SARS-CoV/hACE2 interface, and hence RBD/hACE2 binding affinities are decreased either by NL63-CoV mutations decreasing the tunnel space or by SARS-CoV mutations increasing the tunnel space. Furthermore, NL63-CoV RBD inhibits hACE2-dependent transduction by SARS-CoV spike protein, a successful application of the hot spot theory that has the potential to become a new antiviral strategy against SARS-CoV infections. These results suggest that the structural features of the hot spot on hACE2 were among the driving forces for the convergent evolution of NL63-CoV and SARS-CoV.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Virol</journal-id>
<journal-id journal-id-type="hwp">jvi</journal-id>
<journal-id journal-id-type="pmc">jvi</journal-id>
<journal-id journal-id-type="publisher-id">JVI</journal-id>
<journal-title-group>
<journal-title>Journal of Virology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-538X</issn>
<issn pub-type="epub">1098-5514</issn>
<publisher>
<publisher-name>American Society for Microbiology</publisher-name>
<publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">21411533</article-id>
<article-id pub-id-type="pmc">3094985</article-id>
<article-id pub-id-type="publisher-id">2274-10</article-id>
<article-id pub-id-type="doi">10.1128/JVI.02274-10</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Virus-Cell Interactions</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Virus-Binding Hot Spot on Human Angiotensin-Converting Enzyme 2 Is Critical for Binding of Two Different Coronaviruses
<xref ref-type="fn" rid="FN1">
<sup></sup>
</xref>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Kailang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Lang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peng</surname>
<given-names>Guiqing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Wenbo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pennell</surname>
<given-names>Christopher A.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mansky</surname>
<given-names>Louis M.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geraghty</surname>
<given-names>Robert J.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Fang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="aff1">
<label>1</label>
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</aff>
<aff id="aff2">
<label>2</label>
Center for Drug Design, University of Minnesota, Minneapolis, Minnesota 55455</aff>
<aff id="aff3">
<label>3</label>
Cancer Center, Center for Immunology, University of Minnesota, Minneapolis, Minnesota 55455</aff>
<aff id="aff4">
<label>4</label>
Institute for Molecular Virology and Departments of Diagnostic and Biological Sciences and Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">
<label>*</label>
Corresponding author. Mailing address:
<addr-line>Department of Pharmacology, University of Minnesota Medical School, 6-121 Jackson Hall, 321 Church St. SE, Minneapolis, MN 55455</addr-line>
. Phone:
<phone>(612) 625-6149</phone>
. Fax:
<fax>(612) 625-8408</fax>
. E-mail:
<email>lifang@umn.edu</email>
.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2011</year>
</pub-date>
<volume>85</volume>
<issue>11</issue>
<fpage>5331</fpage>
<lpage>5337</lpage>
<history>
<date date-type="received">
<day>29</day>
<month>10</month>
<year>2010</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>3</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2011, American Society for Microbiology</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder>American Society for Microbiology</copyright-holder>
</permissions>
<self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zjv01111005331.pdf"></self-uri>
<abstract>
<p>How viruses evolve to select their receptor proteins for host cell entry is puzzling. We recently determined the crystal structures of NL63 coronavirus (NL63-CoV) and SARS coronavirus (SARS-CoV) receptor-binding domains (RBDs), each complexed with their common receptor, human angiotensin-converting enzyme 2 (hACE2), and proposed the existence of a virus-binding hot spot on hACE2. Here we investigated the function of this hypothetical hot spot using structure-guided biochemical and functional assays. The hot spot consists of a salt bridge surrounded by hydrophobic tunnel walls. Mutations that disturb the hot spot structure have significant effects on virus/receptor interactions, revealing critical energy contributions from the hot spot structure. The tunnel structure at the NL63-CoV/hACE2 interface is more compact than that at the SARS-CoV/hACE2 interface, and hence RBD/hACE2 binding affinities are decreased either by NL63-CoV mutations decreasing the tunnel space or by SARS-CoV mutations increasing the tunnel space. Furthermore, NL63-CoV RBD inhibits hACE2-dependent transduction by SARS-CoV spike protein, a successful application of the hot spot theory that has the potential to become a new antiviral strategy against SARS-CoV infections. These results suggest that the structural features of the hot spot on hACE2 were among the driving forces for the convergent evolution of NL63-CoV and SARS-CoV.</p>
</abstract>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C65 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000C65 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:3094985
   |texte=   A Virus-Binding Hot Spot on Human Angiotensin-Converting Enzyme 2 Is Critical for Binding of Two Different Coronaviruses▿
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:21411533" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021